Day One Biopharmaceutical... (DAWN)
11.64
0.48 (4.30%)
At close: Jan 15, 2025, 12:49 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 230.78M | 85.26M | 284.31M | 43.73M | 27.33M |
| Short-Term Investments | 135.56M | 257.01M | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 214.00K | 469.00K | 169.00K | 107.00K | n/a |
| Receivables | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 8.93M | 5.61M | 5.06M | 1.34M | 7.00K |
| Total Current Assets | 375.27M | 347.87M | 289.37M | 45.07M | 27.34M |
| Property-Plant & Equipment | 560.00K | 719.00K | 284.00K | 483.00K | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 774.00K | 1.19M | 453.00K | 590.00K | n/a |
| Total Assets | 376.05M | 349.06M | 289.82M | 45.66M | 27.34M |
| Account Payables | 2.58M | 260.00K | 1.74M | 202.00K | 69.00K |
| Deferred Revenue | n/a | n/a | 6.61M | 1.57M | n/a |
| Short-Term Debt | 408.00K | 810.00K | 408.00K | 198.00K | n/a |
| Other Current Liabilities | 26.52M | 15.54M | 6.50M | 1.60M | 1.95M |
| Total Current Liabilities | 29.51M | 16.61M | 8.66M | 2.00M | 2.02M |
| Long-Term Debt | n/a | 408.00K | 16.00K | 204.00K | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | 91.96M | 30.50M |
| Total Long-Term Liabilities | n/a | 408.00K | 16.00K | 92.17M | 30.50M |
| Total Liabilities | 29.51M | 17.02M | 8.67M | 94.16M | 32.52M |
| Total Debt | 408.00K | 813.00K | 220.00K | 402.00K | n/a |
| Common Stock | 9.00K | 7.00K | 6.00K | 2.00M | 2.00M |
| Retained Earnings | -458.58M | -269.67M | -127.49M | -56.84M | -12.78M |
| Comprehensive Income | 9.00K | -71.00K | 0.00 | 637.00 | 111.00 |
| Shareholders Equity | 346.54M | -269.67M | -127.49M | -54.20M | -10.67M |
| Total Investments | 135.56M | 257.01M | n/a | n/a | n/a |